All Posts

Health Technology Assessment (HTA) is quickly moving from an academic idea to a practical tool for decision-making in Kenya. As the country pursues Universal Health Coverage (UHC) and strives to spend scarce health resources wisely, HTA is emerging as the bridge between clinical evidence, economics, and the real priorities of Kenyan patients and policymakers.   This case study traces Kenya’s early steps toward institutionalized HTA, highlights what makes the journey locally r

Health Technology Assessment (HTA) is no longer just a technical exercise, it is a strategic tool for reshaping how health systems in low- and middle-income countries (LMICs) make decisions. Through evaluating the value, cost-effectiveness, and equity impact of health interventions, HTA provides governments and institutions with the evidence needed to allocate scarce resources more effectively.   But building HTA capacity requires more than technical training, it demands inst

Across the world, rapid population growth, a rising burden of non-communicable diseases, and economic constraints mean that governments must make tough choices about which medicines, technologies, and interventions to fund. Health Technology Assessment (HTA) has emerged as a powerful tool to guide decision-making in healthcare.   But while HTA has matured in high-income countries (HICs), its frameworks are often designed for contexts with abundant resources, strong data syste

By Dr. Ahmed Kamau, Health Economist In April 2025, Kenya took a pivotal step toward Universal Health Coverage (UHC) with the gazettement of the Health Benefits Package and Tariffs Advisory Panel. As we embark on this journey, there’s an opportunity to borrow from global best practices, like those of the National Institute for Health and Care Excellence (NICE) in the UK, while acknowledging our unique economic, institutional, and health system realities. Critical Pillars for

Healthcare systems around the world are grappling with the same challenge: how to deliver the best possible care to populations with finite resources. Budgets are not limitless, yet the demand for life-saving medicines, cutting-edge technologies, and innovative therapies keeps rising. Against this backdrop, Health Technology Assessment (HTA) has emerged as one of the most powerful policy tools governments can use to to guide evidence-based, equitable, and sustainable decision

South Africa’s journey toward institutionalised Health Technology Assessment (HTA) offers practical lessons for low- and middle-income countries (LMICs) wrestling with how to make fair, evidence-based choices about medicines and other health technologies. In 2013, South Africa published formal Guidelines for Pharmacoeconomic Submissions  to provide a transparent, consistent way for manufacturers and evaluators to present cost-effectiveness evidence, a landmark step in the reg

For decades, getting a new medicine to market meant proving safety and efficacy to regulators. Today, that’s no longer enough. Increasingly, the decisive factor is Health Technology Assessment (HTA), the process by which governments and payers evaluate whether a new technology is worth funding.   In practical terms, HTA determines not just whether patients get access to innovation, but also how companies design trials, set prices, and even structure their business models.   C

In today’s healthcare landscape, innovation is advancing at a rapid pace. Breakthrough oncology drugs, digital diagnostic tools, implantable medical devices, new technologies promise to transform outcomes for patients. But before these innovations can reach the people who need them, one critical step determines their future: Health Technology Assessment (HTA).   HTA is the process through which policymakers and payers evaluate the evidence surrounding a new health technology,

When we talk about Health Technology Assessment (HTA), the concept can sound abstract, full of frameworks, evidence models, and cost-effectiveness thresholds. But what does it actually look like in practice?   Let’s take a closer look through a real-world example: how the UK’s  National Institute for Health and Care Excellence (NICE)  evaluates new medicines.   Why NICE Matters NICE is one of the world’s most influential HTA bodies. Its decisions shape access to medicines in

When most people hear the term Health Technology Assessment (HTA), they think of spreadsheets filled with cost analyses, clinical trial data, and statistical models. And while these numbers are central, HTA goes far beyond figures on a page.   At its core, HTA is a policy-shaping tool that blends evidence, ethics, and equity to inform how countries regulate health technologies and deliver care that is not only effective but also fair.   HTA in Regulatory and Compliance   Poli

On any given day, health systems around the world face a tough balancing act: how to provide patients with the best possible care while keeping costs under control. Enter Health Technology Assessment (HTA), a structured, evidence-based approach used globally to evaluate the value and cost-effectiveness of health technologies such as vaccines, diagnostics, and medical devices. This critical tool is quietly shaping the future of medicine, policy, and patient care.   At its simp

On a humid Tuesday morning in rural Machakos, a mother walks into a local health center clutching her two-year-old daughter. The child has a persistent cough and fever. The nurse on duty is busy with several patients already waiting, but within minutes, a community health volunteer (CHV) steps in. She takes the child’s vitals using a mobile diagnostic kit, records the symptoms on a digital tablet, and instantly shares the data with a clinical officer miles away.   By the time

Health and AI: What’s Working, What’s Not, and How to Tell the Difference   Health innovation is booming. AI triage chatbots, drone delivery, point-of-care diagnostics, digital adherence tools, you name it. But in public health (and especially in resource-constrained settings), the key question isn’t “is it cool?” it’s “ will it work here, at scale, for real people, at a justifiable cost? ”   Let’s take a deep dive into a practical, evidence-anchored guide to where AI is deli

Hospital accreditation is a strategic driver of patient safety, quality, and operational excellence—but many hospitals face recurring challenges that can delay or compromise success. This article explores the most common pitfalls in accreditation, from insufficient leadership engagement to documentation gaps, and provides actionable strategies to avoid them.

Ineffective hospital policies can compromise patient safety, create regulatory risks, and reduce operational efficiency. Thoughtfully designed policies, however, provide a strategic framework for quality care, compliance, and organizational resilience.

Achieving JCI accreditation is a transformative journey for healthcare organizations, ensuring global standards of patient safety, quality, and operational excellence. This guide outlines a structured, step-by-step approach, highlights common challenges, shares best practices, and demonstrates the tangible ROI of accreditation.

Health systems around the world are under pressure—rising costs, aging populations, and fragmented care are pushing traditional models to the breaking point. At ANK Global Advisors, we see health systems transformation as our guiding north star, driving every partnership and strategy we build.

Groundbreaking therapies promise cures but often come with price tags that overwhelm public budgets and private insurers alike. Hybrid insurance models—where public systems provide universal coverage and private insurers share responsibility for high-cost, innovative treatments—offer a path forward.

Standard Operating Procedures (SOPs) are the backbone of healthcare quality assurance, ensuring consistency, compliance, and patient safety across all clinical and operational processes. By standardizing workflows, enhancing staff accountability, and enabling continuous improvement, SOPs help healthcare organizations deliver reliable, high-quality care.

Is your healthcare growth strategy aligned with today’s evolving market? This blog explores how healthcare organizations can unlock hidden revenue streams through smarter business development and commercial advisory intelligence.